- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Junctional rhythm.
Displaying page 1 of 1.
| EudraCT Number: 2015-001129-17 | Sponsor Protocol Number: LDLL300.301 | Start Date*: 2017-06-19 | ||||||||||||||||||||||||||||||||||||
| Sponsor Name:AOP Orphan Pharmaceuticals GmbH | ||||||||||||||||||||||||||||||||||||||
| Full Title: A multicenter, open-label study to investigate the effectiveness and safety of AOP Landiolol in controlling supraventricular tachycardia in pediatric patients (LANDI-PED). | ||||||||||||||||||||||||||||||||||||||
| Medical condition: Supraventricular tachycardia in pediatric patients. | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
| Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
| Trial protocol: AT (Completed) DE (Ongoing) LT (Completed) HU (Completed) | ||||||||||||||||||||||||||||||||||||||
| Trial results: View results | ||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2018-002979-17 | Sponsor Protocol Number: K620 | Start Date*: 2018-12-17 | |||||||||||||||||||||
| Sponsor Name:Ruprecht-Karls University Heidelberg Medical Faculty, University Hospital | |||||||||||||||||||||||
| Full Title: Use of doxapram as a new antiarrhythmic drug for a specific therapy of atrial fibrillation | |||||||||||||||||||||||
| Medical condition: Paroxysmal or persistent, non-valvular, atrial fibrillation | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: DE (Prematurely Ended) | |||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||
| EudraCT Number: 2005-000204-13 | Sponsor Protocol Number: D1461C00006 | Start Date*: 2005-06-22 | |||||||||||
| Sponsor Name:AstraZeneca AB | |||||||||||||
| Full Title: A double-blind, randomised, placebo-controlled, parallel-group, multicentre, phase II study to assess the efficacy of AZD7009 (AR-H065522XX) given intravenously (infusion for 15 or 30 minutes) to p... | |||||||||||||
| Medical condition: Atrial fibrillation (AF) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: HU (Completed) FI (Completed) SE (Completed) DK (Completed) DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2014-000643-33 | Sponsor Protocol Number: TFR116341 | Start Date*: 2014-08-26 | ||||||||||||||||
| Sponsor Name:GlaxoSmithKline Research & Development Ltd | ||||||||||||||||||
| Full Title: A Placebo Controlled, Double-blind, Multi-centre, Single Dose, Parallel Group, Randomised Clinical Trial of GSK2862277 in Patients undergoing Oesophagectomy Surgery. | ||||||||||||||||||
| Medical condition: Prevention and treatment of Acute Respiratory Distress Syndrome (ARDS) and other acute inflammatory conditions | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.